Blood Purification Equipment is to filter blood by removing the irreversibly damaged red blood cells and toxins before transfusion and reduces the occurrence of post-transfusion complications.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
– Extensive coverage of the Blood Purification Equipment under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Blood Purification Equipment and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Blood Purification Equipment under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accel Diagnostics LLC
- Advanced Prenatal Therapeutics, Inc.
- Aethlon Medical Inc
- Asahi Kasei Medical Co Ltd
- Avalon GloboCare Corp
- Boston Children's Hospital
- Cala Medical Ltd
- Cerus Corp
- Chemofilter Inc (Inactive)
- CytoSorbents Corp
- EBO2 Inc
- Eliaz Therapeutics Inc
- Ex Vivo Dynamics Inc
- ExThera Medical Corp
- Filtro Medical Inc
- Good SIRS
- HemoTune AG
- Immunicom Inc
- JIMRO Co Ltd
- Kohane Lab
- Leukocare AG
- McGowan Institute for Regenerative Medicine
- MediSieve Ltd
- Miltenyi Biotec BV & Co KG
- Nipro Corp
- Nonwovens Innovation & Research Institute Ltd
- NuVascular Technologies Inc
- NxStage Medical Inc
- Opsonix Inc
- Pall Medical Products Inc
- Path Ex Inc
- ProSorp BioTech Inc
- Pure Biologics SA
- Recombinant Technologies LLC
- SanSepsis BV
- Santersus AG
- Sigyn Therapeutics Inc
- Toray Medical Co Ltd
- University of Louisville
- Viatar CTC Solutions Inc
- Zata Pharmaceuticals Inc


 
   
   
   
     
    